A vaccinia-based vaccine (TroVax) targeting the oncofetal antigen 5T4 administered before and after surgical resection of colorectal cancer liver metastases: Phase II trial

2574 Background: Oncofetal antigen5T4 is expressed by most colorectal cancers. Administration of a vaccine combining a Modified Vaccinia Ankara(MVA) vector with 5T4 elicits immune responses in la...